Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rangering i aksjer #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Aksjekurs
$1.51
Sist synkronisert: 2024-08-26
Markedsverdi
$1.12M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategori

Historikk for aksjesplitt for Agile Therapeutics, Inc. (AGRX)
Aksjen Agile Therapeutics, Inc. (symbol: AGRX) har gjennomgått totalt 2 aksjesplitt.
Den nyeste splittelsen skjedde Apr 11, 2023.
Én AGRX-aksje kjøpt før Apr 27, 2022 tilsvarer i dag 0.0005 AGRX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2023-04-11 1:50 x0.02 x0.0005
2022-04-27 1:40 x0.025 x0.025
Aksjesplitt for lignende selskaper eller konkurrenter